BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11236621)

  • 1. Current management of hypertrophic cardiomyopathy.
    Golledge P; Knight CJ
    Hosp Med; 2001 Feb; 62(2):79-82. PubMed ID: 11236621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
    Adabag AS; Maron BJ
    Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics of hypertrophic cardiomyopathy: what is the next step?
    Kuusisto J
    Heart; 2020 Sep; 106(17):1291-1292. PubMed ID: 32546508
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
    Teekakirikul P; Zhu W; Huang HC; Fung E
    Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31888115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of hypertrophic cardiomyopathy.
    Spirito P; Seidman CE; McKenna WJ; Maron BJ
    N Engl J Med; 1997 Mar; 336(11):775-85. PubMed ID: 9052657
    [No Abstract]   [Full Text] [Related]  

  • 9. New concepts in hypertrophic cardiomyopathies, part II.
    Roberts R; Sigwart U
    Circulation; 2001 Oct; 104(18):2249-52. PubMed ID: 11684639
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 12. [Criteria of treatment and prognosis in hypertrophic obstructive cardiomyopathy, obtained from electrocardiographic and catamnestic studies].
    Di Paolo E; Baldi G; Villecco AS
    Boll Soc Ital Cardiol; 1978; 23(9):1501-3. PubMed ID: 45250
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of hypertrophic cardiomyopathy: A review of current state.
    Sabater-Molina M; Pérez-Sánchez I; Hernández Del Rincón JP; Gimeno JR
    Clin Genet; 2018 Jan; 93(1):3-14. PubMed ID: 28369730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy in childhood.
    Colan SD
    Heart Fail Clin; 2010 Oct; 6(4):433-44, vii-iii. PubMed ID: 20869644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 17. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in understanding hypertrophic cardiomyopathy.
    Mohiddin S; Fananapazir L
    Hosp Pract (1995); 2001 May; 36(5):23-5, 29-30, 33-6. PubMed ID: 11361156
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden death.
    Chung WK; Kitner C; Maron BJ
    Cardiol Young; 2011 Jun; 21(3):345-8. PubMed ID: 21262074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.